Carcinomatous Meningitis in Non-Small-Cell Lung Cancer: Response to High-Dose Erlotinib

被引：50

作者：

Dhruva, Nirav ^{[1
]}

Socinski, Mark A. ^{[1
]}

机构：

[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Multidisciplinary Thorac Oncol Program, Chapel Hill, NC 27599 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 22期

关键词：

LEPTOMENINGEAL; GEFITINIB; ADENOCARCINOMA; MUTATION; PATIENT;

D O I：

10.1200/JCO.2008.21.0963

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E31 / E32

页数：2

共 8 条

[1]

BUIE LW, 2007, J CLIN ONCOL S, V25, pS88

[2] Gefitinib response of erlotinib-refractory lung cancer involving meninges -: role of EGFR mutation [J].

Choong, NW ;

Dietrich, S ;

Seiwert, TY ;

Tretiakova, MS ;

Nallasura, V ;

Davies, GC ;

Lipkowitz, S ;

Husain, AN ;

Salgia, R ;

Ma, PC .

NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01) :50-57

[3] Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene [J].

Fukuhara, Tatsuro ;

Saijo, Yasuo ;

Sakakibara, Tomohiro ;

Inoue, Akira ;

Morikawa, Naoto ;

Kanamori, Masayuki ;

Nakashima, Ichiro ;

Nukiwa, Toshihiro .

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 214 (04) :359-363

[4] Leptomeningeal carcinomatosis [J].

Grossman, SA ;

Krabak, MJ .

CANCER TREATMENT REVIEWS, 1999, 25 (02) :103-119

[5] Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib [J].

Jackman, David M. ;

Holmes, Alison J. ;

Lindeman, Neal ;

Wen, Patrick Y. ;

Kesari, Santosh ;

Borras, Ana M. ;

Bailey, Christopher ;

de Jong, Francisca ;

Jaenne, Pasi A. ;

Johnson, Bruce E. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4517-4520

[6] Management of leptomeningeal malignancy [J].

Pentheroudakis, G ;

Pavlidis, N .

EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (07) :1115-1125

[7] Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib [J].

Sakai M. ;

Ishikawa S. ;

Ito H. ;

Ozawa Y. ;

Yamamoto T. ;

Onizuka M. ;

Sakakibara Y. .

International Journal of Clinical Oncology, 2006, 11 (3) :243-245

[8] Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma [J].

Wagner, Mathilde ;

Besse, Benjamin ;

Balleyguier, Corinne ;

Soria, Jean-Charles .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) :677-679

← 1 →